Perspective Therapeutics CATX
NYSE CATX
$3.22 -0.26 (-7.47%)
As of: Aug 20, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Net Margin (QoQ) (2010 - 2023)

Perspective Therapeutics (CATX) Net Margin (QoQ) (2010 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Perspective Therapeutics 389.10 Mn 389.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 14,161.00
Sep 30, 2023 7,212.00
Jun 30, 2023 -3,694.00
Sep 30, 2022 -6,669.00
Jun 30, 2022 791.00
Mar 31, 2022 1,067.00
Dec 31, 2021 3,052.00
Sep 30, 2021 -4,833.00
Jun 30, 2021 -1,050.00
Mar 31, 2021 814.00
Dec 31, 2020 -676.00
Sep 30, 2020 2,223.00
Jun 30, 2020 -3,323.00
Mar 31, 2020 2,172.00
Dec 31, 2019 -537.00
Sep 30, 2019 2,169.00
Jun 30, 2019 166.00
Mar 31, 2019 1,564.00
Dec 31, 2018 2,237.00
Sep 30, 2018 5,055.00